TARO PHARMACEUTICALS CANADA
Chetana Bhave is a skilled Regulatory Affairs professional with extensive experience in the pharmaceutical industry. Currently serving as a Regulatory Affairs Associate at Taro Pharmaceuticals Canada since April 2023, Chetana has previously held notable positions including Regulatory Affairs Executive at Lupin from November 2017 to November 2021, and Regulatory Affairs Officer at Indoco Remedies Ltd. and Glenmark Pharmaceuticals from January 2017 to January 2017 and March 2015 to January 2017, respectively. Chetana began the professional journey as a Technical Officer at the Institute of Pharmaceutical Management from August 2014 to March 2015. Educationally, Chetana holds a PG Diploma in Drug Regulatory Affairs from the Institute of Pharmaceutical Management (2014) and a Bachelor of Pharmacy (BPharm) in Pharmaceutical Sciences from the University of Mumbai (2011-2014).
This person is not in any teams
TARO PHARMACEUTICALS CANADA
We are a global, research-driven, specialty pharmaceutical company. Established in 1950, Taro develops, manufactures and markets affordable prescription and over-the counter medications. With support from our parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company we are a powerful global presence. Our world class production facilities in Brampton, Ontario and nearly 600 Canadian employees give Taro Canada a uniquely Canadian perspective. Our Canadian focus on dermatology makes us a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from our competitors. We specialize in generic prescription products, but also produce over the counter and brand name drugs. Our strong research program and niche strategy have positioned us as a central player in the specialty pharmaceutical sector.